Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett(Wellcome Sanger Institute), Daniel A. Haber(Howard Hughes Medical Institute), Ivan Stamenkovic(University Hospital of Lausanne), Chris Greenman(University of East Anglia), Syd Barthorpe(Wellcome Sanger Institute), Xianming Deng(Xiamen University), Randy Milano(Harvard University), Nathanael S. Gray(Stanford University), Olivier Delattre(Institut Curie), Helen Thi(Harvard University), Stephen Lutz(Harvard University), Jeffrey A. Engelman(Cancer Research Center), Karl Lawrence(Wellcome Sanger Institute), Xeni Mitropoulos(Harvard University), Wooyoung Hur(Hanyang University), I. Richard Thompson(Wellcome Sanger Institute), Jesse A. Stevenson(Harvard University), Patrick O’Brien(Wellcome Sanger Institute), Frances Jewitt(Wellcome Sanger Institute), Graham R. Bignell(Lund University), Wanjuan Yang(Wellcome Sanger Institute), P. Andrew Futreal(Wellcome Sanger Institute), Fiona Kogera(Wellcome Sanger Institute), Elena J. Edelman(Harvard University), Tatiana Mironenko(Wellcome Sanger Institute), Anne McLaren-Douglas(Wellcome Sanger Institute), Helen Davies(German Cancer Research Center), Sreenath V. Sharma(Harvard University), Ah Ting Tam(Harvard University), Laura Richardson(Wellcome Sanger Institute), Stacey Price(Wellcome Sanger Institute), Francesco Iorio(Human Technopole), King Wai Lau(Wellcome Sanger Institute), Jeffrey Settleman(Enzo Life Sciences (United States)), Didier Surdez(Institut Curie), Patricia Greninger(Harvard University), Anahita Dastur(Harvard University), Hwan Geun Choi(Harvard University), Li Chen(Harvard University), Xi Luo(Harvard University), Wenjun Zhou(Shanghai Innovative Research Center of Traditional Chinese Medicine), Jae Won Chang(Chungnam National University), Jorge Soares(Wellcome Sanger Institute), Tinghu Zhang(Stanford University), Sonja J. Heidorn(Institute of Cancer Research), Adam P. Butler(Wellcome Sanger Institute), Qingsong Liu(Medical College of Wisconsin), José Baselga(Novartis (Switzerland)), Jessica L. Boisvert(Harvard University), Julio Sáez-Rodríguez(European Bioinformatics Institute)
Cited by 2,565
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Drug repurposing: progress, challenges and recommendations
|Nature Reviews Drug Discovery|2018|4.6k